WELCOME

60505-6244-04

J0690

INJECTION, CEFAZOLIN SODIUM, 500 MG

PREMIERPRO RX CEFAZOLIN (PHARMACY BULK PKG,AF,PF) 10 GM

IV

60505-6245-04

J0692

INJECTION, CEFEPIME HYDROCHLORIDE, 500 MG

PREMIERPRO RX CEFEPIME (SDV) 1 GM

IJ

60505-6246-04

J0692

INJECTION, CEFEPIME HYDROCHLORIDE, 500 MG

PREMIERPRO RX CEFEPIME (SDV) 2 GM

IJ

60505-6272-01

J9206

INJECTION, IRINOTECAN, 20 MG

IRINOTECAN HCL NOVAPLUS (SDV,PF,LATEX-FREE) 20 MG/1 ML

IV

60505-6277-00

J9060

INJECTION, CISPLATIN, POWDER OR SOLUTION, 10 MG

CISPLATIN (MDV,PF,LATEX-FREE) 1 MG/1 ML

IV

60687-0149-11

None

CAPECITABINE, 500 MG, ORAL

CAPECITABINE (INNER NDC,FILM-COATED) 500 MG

PO

60687-0149-94

None

CAPECITABINE, 500 MG, ORAL

CAPECITABINE (2X10,FILM-COATED) 500 MG

PO

60687-0252-86

Q0162

ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN

ONDANSETRON 4 MG/5 ML

PO

60687-0394-83

J7644

IPRATROPIUM BROMIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM

IPRATROPIUM BROMIDE (30X2.5ML,PF) 0.02%

IH

60687-0394-83

J7644

IPRATROPIUM BROMIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM

IPRATROPIUM BROMIDE (30X2.5ML,PF) 0.02%

IH

60687-0395-83

J7613

ALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 1 MG

ALBUTEROL SULFATE 0.083%

IH

60687-0395-83

J7613

ALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 1 MG

ALBUTEROL SULFATE 0.083%

IH